Tandem Diabetes Care, headquartered in San Diego, California, is a publicly traded medical device company that develops insulin pump systems and continuous glucose monitoring technology for diabetes management. Founded in 2006 by Kevin Sayer, the company has grown to approximately 1,700 employees and trades on NASDAQ under ticker TNDM. The company is known for its t:slim X2 insulin pump platform, which features automated insulin delivery and seamless integration with continuous glucose monitors, setting it apart in the diabetes care market. Tandem operates globally and continues to expand access to advanced diabetes management technology. The company reflects strong growth in the adoption of automated insulin delivery systems and increasing international demand for user-friendly diabetes management tools.
Tandem Diabetes Care operates with a mission-driven culture centered on improving health and quality of life for people with diabetes. The company emphasizes innovation in product design and user experience, with engineering teams focused on developing practical, patient-centered solutions. Quality and regulatory compliance are foundational across all operations, reflecting the critical nature of medical devices. The company recruits talented engineers, software developers, and healthcare professionals who are passionate about advancing diabetes care technology and accessible healthcare innovation.
70 open now, 70 first appeared in the last 30d.